A detailed history of Cottage Street Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Cottage Street Advisors LLC holds 2,482 shares of AMGN stock, worth $771,331. This represents 0.43% of its overall portfolio holdings.

Number of Shares
2,482
Previous 2,446 1.47%
Holding current value
$771,331
Previous $712 Million 0.95%
% of portfolio
0.43%
Previous 0.48%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$268.87 - $324.56 $9,679 - $11,684
36 Added 1.47%
2,482 $706 Million
Q3 2023

Nov 06, 2023

BUY
$218.65 - $271.46 $26,675 - $33,118
122 Added 5.25%
2,446 $657 Million
Q2 2023

Jul 24, 2023

BUY
$214.27 - $253.37 $214 - $253
1 Added 0.04%
2,324 $516 Million
Q1 2023

Apr 21, 2023

BUY
$225.79 - $275.2 $524,510 - $639,289
2,323 New
2,323 $562 Million
Q3 2022

Oct 27, 2022

BUY
$224.46 - $253.15 $224 - $253
1 Added 0.04%
2,322 $523,000
Q1 2022

Apr 20, 2022

BUY
$219.27 - $242.57 $219 - $242
1 Added 0.04%
2,321 $561,000
Q4 2021

Jan 13, 2022

BUY
$198.88 - $227.6 $7,358 - $8,421
37 Added 1.62%
2,320 $522,000
Q3 2021

Oct 12, 2021

BUY
$212.27 - $248.7 $13,160 - $15,419
62 Added 2.79%
2,283 $485,000
Q2 2021

Jul 20, 2021

BUY
$233.58 - $259.14 $3,036 - $3,368
13 Added 0.59%
2,221 $541,000
Q1 2021

Apr 22, 2021

BUY
$221.91 - $258.6 $1,775 - $2,068
8 Added 0.36%
2,208 $549,000
Q3 2020

Oct 08, 2020

SELL
$234.65 - $260.95 $93,860 - $104,380
-400 Reduced 15.38%
2,200 $559,000
Q2 2020

Jul 09, 2020

SELL
$197.81 - $242.74 $10,879 - $13,350
-55 Reduced 2.07%
2,600 $613,000
Q3 2019

Oct 24, 2019

BUY
$174.11 - $208.62 $174 - $208
1 Added 0.04%
2,655 $514,000
Q2 2019

Aug 02, 2019

SELL
$166.7 - $195.41 $227,712 - $266,930
-1,366 Reduced 33.98%
2,654 $489,000
Q1 2019

May 01, 2019

BUY
$180.87 - $203.88 $180 - $203
1 Added 0.02%
4,020 $764,000
Q3 2018

Nov 05, 2018

SELL
$185.29 - $208.89 $83,380 - $94,000
-450 Reduced 10.07%
4,019 $832,000
Q2 2018

Aug 07, 2018

SELL
$166.05 - $186.51 $672,336 - $755,178
-4,049 Reduced 47.53%
4,469 $825,000
Q1 2018

Apr 27, 2018

SELL
$169.43 - $198.0 $93,186 - $108,900
-550 Reduced 6.07%
8,518 $1.45 Million
Q4 2017

Jan 16, 2018

SELL
$168.79 - $188.59 $127,267 - $142,196
-754 Reduced 7.68%
9,068 $1.58 Million
Q3 2017

Oct 17, 2017

BUY
$167.29 - $191.0 $1.64 Million - $1.88 Million
9,822
9,822 $1.83 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cottage Street Advisors LLC Portfolio

Follow Cottage Street Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cottage Street Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cottage Street Advisors LLC with notifications on news.